Document Detail


Long-term outcome of patients on continuous-flow left ventricular assist device support.
MedLine Citation:
PMID:  25260275     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: Recent advances in technology and improved patient management have enabled the use of mechanical circulatory support for unexpected long-term periods. Improved long-term outcomes may facilitate the use of device therapy as an alternative to heart transplantation. However, there are scarce data about the long-term outcomes of continuous-flow left ventricular assist devices. This study sought to evaluate the long-term outcomes in patients receiving continuous-flow left ventricular assist devices.
METHODS: Between March 2004 and June 2010, 140 patients underwent continuous-flow left ventricular assist device insertion as a bridge to transplantation or a destination therapy. These patients' charts were retrospectively reviewed.
RESULTS: The initial strategy for continuous-flow left ventricular assist device therapy was bridge to transplantation in 115 patients (82%) and destination therapy in 25 patients (18%). Of those, 24 (17%) died on left ventricular assist device support, 94 (67%) were successfully bridged to transplantation, and 1 (0.71%) showed native heart recovery. Twenty-four patients (17%) had been on continuous-flow left ventricular assist device support for more than 3 years (mean, 3.9 years; range, 3.0-7.5 years). Estimated on-device survival at 1, 3, and 5 years was 83%, 75%, and 61%, respectively. Rehospitalizations due to bleeding, cardiac events, and device-related issues were common. The freedom from rehospitalization rates at 1 and 3 years was 31% and 6.9%, respectively. A total of 14 patients (10%) required device exchange.
CONCLUSIONS: Current continuous-flow left ventricular assist devices can provide satisfactory long-term survival. However, rehospitalization is frequently required.
Authors:
Koji Takeda; Hiroo Takayama; Bindu Kalesan; Nir Uriel; Paolo C Colombo; Ulrich P Jorde; Yoshifumi Naka
Related Documents :
25190705 - Tbx1 coordinates addition of posterior second heart field progenitor cells to the arter...
2889585 - An experimental contribution to the treatment of acute myocardial infarction.
10925235 - Cannulation of the cardiac lymphatic system in swine.
21808645 - Assessing the left ventricular systolic function at the bedside: the role of transpulmo...
1635965 - Beat-by-beat cardiac responses in normals and schizophrenics to events varying in condi...
23791165 - Predicting right ventricular failure in the modern, continuous flow left ventricular as...
Publication Detail:
Type:  Journal Article     Date:  2014-04-12
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  148     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-09-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1606-14     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expanding the indication for sutureless aortic valve replacement to patients with mitral disease.
Next Document:  Hospitalization before surgery increases risk for postoperative infections.